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Microsurgical Lymph Node Dissection for Metastatic Asymptomatic 
C-Cell Carcinoma 
Heinz J. Buhr,* Friedrich Kallinowski,* Friedhelm Raue,+ and Christian Herfarth' 
In persistent, clinically Inapparent medullary thyroid carcinoma, microsurgical dissection of all 
lymph node compartments ofthe neck was performed. Beti'een August 1988 and September 1991,28 
cases (mean age 43.3 years) were treated with 38 .surgical interventions. Twenty patients had the 
sporadic form and eight patients the famdial form. Unilateral neck dissection resulted in nor-
malization of serum calcitonin (CT) levels even after pentagastrin stimulation in two patients whereas 
16 patients exhibited abnormal CT stimulation tests. Eight of ten patients who had bilateral neck 
dissections had positive pentagastrin test results after surgery. The main postoperative complications 
included loss of local cutaneous sensation, generally temporary, and unilateral recurrent laryngeal 
nerve paralysis. (Henry Ford Hosp Med J1992:40:268-70) 
Approximately 30 new cases of medullary thyroid carci-noma (MTC) are observed per 1 million population in the 
Federal Republic of Germany. MTC, representing between 5% 
and 10% ofthe malignant diseases of the thyroid, is a relatively 
rare disease. However, it exhibits several unique biological fea-
tures. The surgical treatment of metastasizing but clinically oc-
cult MTC is based on these biological features: 
1. Early metastases are noted in regional lymph nodes of the 
neck and the mediastinal area, followed by a long interval before 
distant metastases become obvious (1). During family screen-
ing, Wells et al (2) detected lymph node metastases in 50% of 
the patients with elevated basal calcitonin (CT) levels. In pa-
tients with clinically detectable tumor masses, this rate in-
creased to 7f%. 
2. The node status is of prognostic relevance (3-5). The clas-
sic data by Woolner et al (6) indicate 10-year survival rates of 
85% in patients without lymph node metastases, which is not 
significantly different from that of an apparently healthy cohort. 
In patients with lymph node metastases, survival dropped sig-
nificandy to 42%. 
3. MTC is almost radio- and drug-resistant. 
The only potentially curative therapeutic modality is the com-
plete surgical removal of tumor tissue including diseased re-
gional lymph nodes. Consequently, Tisell et al (7) introduced 
the en-bloc-dissection of the lymphatic tissue of the neck and 
mediastinal area into the therapy of MTC. Using this method 
and employing microsurgical techniques, all lymph node com-
partments ofthe central and lateral neck areas and the mediasti-
nal lymphatic tissue are removed. 
sound, computed tomography) failed to visualize the involved 
lymph nodes. Preoperatively, selective venous catheterization 
was performed. Using this technique (8), a concentration peak 
indicative of the site of CT production was obtained suggesting 
which side of the neck to perform the primary microdissection 
using Tisell et al's method (7). A complete dissection of all lym-
phatic tributaries sparing the carotid artery, the jugular vein, and 
all nerves was achieved with the help of microsurgical tech-
niques. During a single operative session, only one side of the 
neck was dissected in order to avoid an excessive duration of 
surgery (9). The mean time required for an operation was 6 
hours (range 4 to 8 hours). The anatomical landmarks for the 
dissection included laterally the edge of the trapezius muscle, 
proximally the mandible or dorsally the occiput, caudally the 
subclavian vein, and towards the mediastinum the brachioce-
phalic vein. 
Patients 
Between August 1988 and September 1991, we treated 28 pa-
tients (15 males, 13 females) with persistendy occult MTC us-
ing these techniques. The mean age was approximately 43 years 
(range 14 to 65 years). A total of 38 neck dissections were per-
formed on these 28 patients. Twenty patients had sporadic MTC 
and eight had familial MTC (multiple endocrine neoplasia type 
2 [MEN 2] syndrome). A total of 28 neck dissections were per-
formed in the 20 patients with the sporadic form (mean age 47 
years). The average interval between primary thyroidectomy 
andthe microsurgical lymph node dissection was 1.1 years. The 
Methods 
In our study, all 28 patients exhibited occult metastases in re-
gional neck lymph nodes as demonstrated by abnormal basal or 
pentagastrin-stimulated CT levels. Imaging techniques (ultra-
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eight MEN 2 patients (mean age 34.5 ± 6 years) had 10 surgical 
interventions with a mean interval between thyroidectomy and 
lymph node dissection of 6.2 years. A cure is defined as a nor-
mal CT value after pentagastrin stimulation. 
Results 
Unilateral neck dissection/sporadic form 
One of 12 patients with sporadic MTC was cured. Eleven pa-
tients exhibit persistently elevated serum CT values, some ba-
sally and some only after pentagastrin stimulation. 
Unilateral neck dissection/MEN 2 
One of six MEN 2 patients had a normal CT response after 
stimulation whereas five patients exhibited a pathological ele-
vation. 
In the 16 sporadic and MEN 2 patients with abnormal postop-
erative pentagastrin stimulation tests, basal semm CT concen-
trations were normal in 12 patients (up to 0.3 p.g/L); two patients 
had values below 0.1 p.g/L; and 10 patients had values between 
O.I and 0.3 \xg/L. Slightly elevated basal serum CT levels were 
observed in four patients. 
Bilateral neck dissection/sporadic form 
Postoperative serum CT levels of two of eight patients were 
within normal limits both basally and after pentagastrin stimula-
tion whereas the values of six patients were above the normal 
range after stimulation. 
Bilateral neck dissection/MEN 2 
Both patients exhibit elevated serum CT levels after pen-
tagastrin stimulation. 
Group results 
It should be noted that a marked postoperative reduction of 
the basal and stimulated CT levels was achieved in all patients, 
even in those eight with persistently abnormal pentagastrin 
stimulation tests. 
The Table lists the lymph node compartments involved in all 
38 patients. MTC was detected in the lateral neck and medi-
astinum in two of four patients with normal postoperative pen-
tagastrin stimulation tests. A high percentage of patients with el-
evated CT levels had lymph node metastases in the lateral neck 
and the mediastinal compartments. 
Postoperatively, several patients had complications which 
were mostly transient in nature. Most common were cutaneous 
nerve lesions which were transient and attributable to the metic-
ulous dissection over a wide distance, compression by retrac-
tors, and similar factors. The loss of cutaneous nerve function 
was only partial; function was generally regained within the first 
three months after hospital discharge. 
The second most common side effect, permanent hypo-
parathyroidism, was observed in only one patient. Intraopera-
tively, it was difficult to preserve the vascular pedicle of at least 
one parathyroid gland due to excessive scarring caused by pre-
vious operations. In these cases, the glandular tissue was identi-
fied by analysis of frozen sections and replanted into the stemo-
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Table 
Lymph Node Compartments Found to be Involved 
After 38 Microsurgical Neck Dissections 
Compartment 
Calcitonin* 
Within Normal Limits Elevated 
Central 2 21 
Lateral 2 18 
Mediastinal 2 15 
*Calcitonin indicates postoperative serum calcitonin concentrations after pentagastrin 
stimulation. 
cleidoid musculature. Transient hypoparathyroidism was usu-
ally mild and short-lasting. Ten patients exhibited delayed clo-
sure of the wound attributable to a lymphatic fistula in six pa-
tients. All fistulae were conservatively treated and closed spon-
taneously within two weeks. In one patient, excessive postoper-
ative bleeding required surgical intervention. Two patients de-
veloped unilateral palsy of the recurrent nerve. 
Discussion 
MTC is a rare disease with characteristic biological features. 
National and intemational tumor registries facilitate research ef-
forts to expand our knowledge of these biological properties 
(10,11). However, little experience has been gained in the suc-
cessful treatment of occult metastatic MTC. There is clear evi-
dence that measurements of the specific tumor marker CT per-
mit the evaluation of the completeness and the success of any 
surgical intervention (12-16). Elevated basal or pentagastrin-
stimulated CT values after primary surgery (thyroidectomy) in-
dicate persistent disease. In most cases, occult metastases unde-
tectable by available imaging techniques are responsible for ab-
normal CT levels. Selective venous catheterization can aid in 
the site-selection for further treatment. Elevated postoperative 
CT levels have been demonstrated to influence the prognosis 
(5). If it is possible to normalize serum CT concentrations, a fa-
vorable outcome can be expected (17). Tisell et al (7) have used 
microsurgical techniques to achieve complete lymph node dis-
sections. Experience to date suggests that this method holds the 
greatest potential for cure. Following this rationale, we treated 
28 patients with elevated pentagastrin-stimulated CT levels who 
had already received a total thyroidectomy as the primary ther-
apy. The metastases could not be detected with available imag-
ing techniques. In four of these 28 patients, microsurgical lymph 
node dissection achieved a biochemical cure as evidenced by 
the normalization of the pentagastrin stimulation test. The com-
plication rate was not excessive. Cutaneous nerve lesions which 
comprised the majority of postoperative complications usually 
disappeared within several months after surgery (18). Further 
follow-up is necessary to determine whether a potential increase 
in cure rates by the microsurgical lymph node dissection out-
weighs the possible complications of surgery. Tisell's technique 
resulted in normalization of basal and pentagastrin-stimulated 
CT levels even years after the primary diagnosis of metastatic 
MTC, and a significant reduction of the tumor burden is 
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achieved by the extensive microsurgical lymph node dissection. 
Whether or not we will observe the long-term cures reported by 
Tisell et al (7) remains to be determined because of the limited 
postoperative observation period. 
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